Insulet Corp: Form 10-K for the period ended Dec 31, 2015
Filed with the SEC on Feb 29, 2016 and accepted by EDGAR at Feb 29, 2016, 07:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-10-01 to 2015-12-31 | $100.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2015-01-01 to 2015-12-31 | $176.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2015-10-01 to 2015-12-31 | $45.3m | us-gaap:GrossProfit |
| Gross profit | 12 months2015-01-01 to 2015-12-31 | $148.2m | us-gaap:GrossProfit |
| Research and development | 12 months2015-01-01 to 2015-12-31 | $43.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2015-01-01 to 2015-12-31 | −$60.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2015-01-01 to 2015-12-31 | $291.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-10-01 to 2015-12-31 | −$27.3m | us-gaap:NetIncomeLoss |
| Net income | 12 months2015-01-01 to 2015-12-31 | −$73.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-10-01 to 2015-12-31 | −$0.48 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 12 months2015-01-01 to 2015-12-31 | −$1.29 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2015-01-01 to 2015-12-31 | −$12.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2015-01-01 to 2015-12-31 | $10.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2015-12-31 | $122.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-12-31 | $190.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-12-31 | $275.1m | us-gaap:Assets |
| Current liabilities | At period end2015-12-31 | $65.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-12-31 | $241.1m | us-gaap:Liabilities |
| Long-term debt | At period end2015-12-31 | $171.7m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2015-12-31 | $34.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-16-000083. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.